Hybrid (onsite minimum of three days per week with flexibility)
Medical strategy for novel biologic
Lead high-performing team
Drive product launches
AstraZeneca is seeking a US Head of Medical for COPD to lead the medical strategy and execution for a novel monoclonal antibody targeting Interleukin-33. The ideal candidate will have extensive experience in the pharmaceutical industry, particularly in Medical Affairs, and a strong background in respiratory disease
Job Summary
This role owns the medical strategy and execution for a novel Interleukin-33 targeting monoclonal antibody, crafting both product and disease area direction across the full lifecycle.
Lead and grow the COPD US medical team, setting clear vision, priorities and standards for excellence in disease area and brand strategy and execution.
AstraZeneca offers an environment where medical leaders sit at the intersection of science and real-world practice, using evidence to influence how care is delivered today and tomorrow.
Matching Summary
Match Score: 85
AstraZeneca is seeking a US Head of Medical for COPD to lead the medical strategy and execution for a novel monoclonal antibody targeting Interleukin-33. The ideal candidate will have extensive experience in the pharmaceutical industry, particularly in Medical Affairs, and a strong background in respiratory disease.
Skills & Requirements
Must-have
Medical strategy for novel biologic
Lead high-performing team
Drive product launches
Shape clinical practice and care pathways
Manage medical budgets and resource planning
External stakeholder relationship building
Nice-to-have
Transforming healthcare initiatives
Influence cross-functional investment decisions
Bold real-world studies
Pioneering launches that shift treatment paradigms
Key Requirements
Sophisticated Scientific Degree (MBBS, PharmD, PhD, or MD)
Minimum 7 years pharmaceutical industry experience
Medical/clinical/scientific expertise in Respiratory Disease
Experienced team leader
Track record delivering results in a matrix environment